COVID-19

From COVID-19 to new vaccines for cancer, influenza, and malaria, read recent news of interest from the world of infectious diseases, with a focus on vaccinology research …

Recent news headlines about COVID-19 vaccines have been focused on concerns about safety and effectiveness. Public health authorities in the US and Europe are reviewing reports of a rare blood clotting disorder among some vaccine recipients, as well as rare reports of breakthrough illnesses in fully vaccinated individuals. In this episode of the Schaffner Report, NFID Medical Director William Schaffner, MD, talks with NFID Executive Director and CEO Marla Dalton about the significance of these reports and the implications for COVID-19 vaccination efforts in the US …

During World Immunization Week, NFID will host the virtual 2021 Annual Conference on Vaccinology Research (ACVR) on April 26-27, 2021, with presentations from leaders in the field of vaccinology, including three keynote lectures on the implications of the COVID-19 pandemic. Read more about the changes and challenges these renowned experts have seen throughout their remarkable careers …

The COVID-19 pandemic has confronted health communicators with unprecedented challenges. To achieve widespread “vaccine literacy,” health communicators must apply basic educational principles to promote trustworthy, straightforward communication …

A nationwide COVID-19 vaccination program is currently underway in the US. Where can you get vaccinated and when? What side effects can you expect? Will COVID-19 vaccines help end the pandemic? Read recent news of interest from the world of infectious diseases, with a focus on COVID-19 vaccination …

The Advisory Committee on Immunization Practices (ACIP) recently held two important meetings to review data on vaccines for influenza, hepatitis, pneumococcal disease, shingles, and other diseases, and to approve the new Janssen COVID-19 vaccine. Marla Dalton, executive director and CEO of the National Foundation for Infectious Diseases (NFID), talks with NFID Medical Director William Schaffner, MD, about the significance of these meetings for healthcare professionals and the public …

As we continue to tackle health equity issues, it is important to be open to embracing new partners and creating new champions. Although highlighting the contributions of Black scientists during Black History Month is important, addressing health equity can and should be done anytime and anywhere …

In honor of American Heart Month, NFID and the American Heart Association (AHA)—a proud supporter of the NFID Keep Up The Rates campaign—encourage individuals with chronic conditions to receive all of their recommended vaccines, despite delays that may have been caused by the COVID-19 pandemic …

COVID-19 cases, hospitalizations, and deaths are starting to decline in the US, and vaccination rates are starting to increase. However, public health experts are concerned about new variants, the possibility of reinfection, and the overall risk of complacency. In this episode of the Schaffner Report, NFID Executive Director and CEO Marla Dalton, CAE, talks with NFID Medical Director William Schaffner, MD, about COVID-19 vaccines, masks, and reinfection …

Only 49 percent of US Black adults plan to get a COVID-19 vaccine, and 54 percent have received or plan to get an influenza (flu) vaccine during the 2020-2021 flu season. These findings were among the results of a new survey of US Black adults conducted by NFID to better understand beliefs about COVID-19 and flu, as well as attitudes and practices around vaccination …

Given the increased rates of vaccine hesitancy among the communities that have been hardest hit by the pandemic, health equity principles should be applied across the board to overall COVID-19 response and vaccine administration …

NFID and the National Alliance for Hispanic Health encourage all Hispanics to receive recommended vaccines that may have been delayed during the COVID-19 pandemic …